Related Experiment Video
Updated: Feb 12, 2026
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Endobronchial biopsy in the final diagnosis of chronic obstructive pulmonary disease and asthma: a
Maria Abdulrahim Arafah1, Emad Raddaoui, Faisal Al Kassimi
1Dr. Maria Abdulrahman Arafah, Department of Pathology,, College of Medicine, King Saud University,, PO Box 2925, Riyadh 11461,, Saudi Arabia, M: +966555214611, marafah83@ gmail.com, ORCID: http://orcid. org/0000-0002-6847-5884.
Background:
Asthma and chronic obstructive pulmonary disease (COPD) are chronic conditions with an increasing prevalence in developing countries. The evaluation of endobronchial biopsies has emerged as a tool to differentiate between both conditions via the measurement of the reticular basement membrane (RBM) thickness with various conclusions drawn from different studies.
Objectives:
Compare the thickness of the RBM between asthma and COPD and evaluate other histomorphological features in both groups.
Design:
Prospective, descriptive and analytical.
Setting:
University teaching hospital.
Patients And Methods:
The study included patients with COPD and irreversible and reversible asthma with diagnosis based on clinical assessment, pulmonary function tests and high-resolution computed tomography scans. Endobronchial biopsies were obtained from all patients and, using a light microscope and a computerized image analyzer, the thickness of the reticular basement membrane was calculated in all patients. We also made a qualitative assessment of other histo-morphological features.
Main Outcome Measures:
Mean RBM thickness.
Sample Size:
Thirty male patients.
Results:
The mean RBM thickness in asthmatic patients was 8.9 (2.4) micro m. The mean RBM thickness in COPD patients was 5.3 (1.1) micro m. However, there was no thickening of the RBM in patients with reversible asthma. The RBM was significantly thicker in patients with irreversible asthma than in patients with COPD or reversible asthma. There were no significant differences in epithelial desquamation or metaplasia, mucosal or submucosal inflammation, the presence of eosinophils, submucosal glandular hyperplasia or submucosal smooth muscle hyperplasia between groups.
Conclusions:
The thickness of the RBM is the only reproducible histopathological feature to differentiate COPD from irreversible asthma.
Limitations:
The study included a limited number of patients. A qualitative approach was used to compare epithelial cell injury, inflammation, submucosal glandular and muscular hyperplasia.
Conflict Of Interest:
None.
More Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment